Alzheimer disease trials in New Zealand

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Trial of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease or Primary Tauopathies

  Where

  Grafton

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Arrowhead Pharmaceuticals

  See details and how to joinNCT07221344
• Phase 1Taking people
  A Study of LY3439539 in Participants With Alzheimer's Disease

  Where

  Christchurch

  Age

  50 years to 85 years

  People

  30 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07598370
• Phase 2/3Taking people
  A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  Where

  Christchurch

  Age

  18 years and over

  People

  280 worldwide

  Run by

  Washington University School of Medicine

  See details and how to joinNCT05552157
• Phase 2/3Taking people
  A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  Where

  Christchurch

  Age

  18 years and over

  People

  280 worldwide

  Run by

  Washington University School of Medicine

  See details and how to joinNCT06647498